Novo Nordisk

Danish pharma; GLP-1 originator (Ozempic 2017, Wegovy 2021). CagriSema (cagrilintide + semaglutide) FDA submission filed December 2025. Diabetes care leader; Novo Holdings acquired Catalent in 2024 to expand fill-finish capacity.

$NVOBagsværd, Denmark64,300Drug Manufacturers - Generalnovonordisk.com

SectorsGLP-1

SEC Filings & Documents

Browse all official SEC filings including annual reports, quarterly updates, and material event disclosures.

No Filings Available

SEC filings for this company are not available at the moment.

Novo Nordisk

Compare Novo Nordisk…

$NVOBagsværd, Denmark64,300Drug Manufacturers - Generalnovonordisk.com

SectorsGLP-1

SEC Filings & Documents

Browse all official SEC filings including annual reports, quarterly updates, and material event disclosures.

No Filings Available

SEC filings for this company are not available at the moment.

Ask Sterling

Novo Nordisk

SEC Filings & Documents

No Filings Available

Novo Nordisk

SEC Filings & Documents

No Filings Available